Searching for Ideal Oxazolidinone for Treatment of Tuberculosis

Read full text Summarise with VIRAT
Authors: А. I. Gayda, Г. Н. Можокина, Элеонора Рафаиловна Переверзева, M. I. Romanova, Абрамченко Анна Валентиновна, А. G. Samoylova
Cited by: 0
References: 49

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Oxazolidinones represent a promising class of drugs for treatment of multidrug-resistant tuberculosis (MDR-TB). Linezolid, the first representative of this class, is highly effective; however, its use is limited due to its toxicity (myelosuppression, neuropathy). 63 publications were analyzed in order to search for new oxazolidinones for treatment of tuberculosis. New drugs and compounds (tedizolid, sutezolid, contezolid, delpazolid, and TBI-223) have a more favorable safety profile with antimycobacterial activity similar to or even greater than that of linezolid. In the coming years, these compounds may become an important component of short, safe, and effective chemotherapy regimens for tuberculosis.

Fields of Study & Subjects

Tuberculosis Research and Epidemiology Antibiotics Pharmacokinetics and Efficacy Infectious Diseases and Tuberculosis

Publication details

Journal / source
Tuberculosis and lung diseases
Volume
104
Issue
1
Pages
114–125
Publication date
22 March 2026
Language
EN